PharmacoEconomics & Outcomes News 432 - 4 Oct 2003 Pharmacist care improves outcomes in depression A collaborative care intervention involving clinical pharmacists can improve quality of care among primary- care patients with depression, and has a "favourable impact on institutional resources", say US-based researchers. They assessed outcomes among 125 members of a health maintenance organisation who started antidepressant medication to treat depressive symptoms; patients were randomised to an intervention group comprising pharmacist case management, patient education and frequent telephone and face-to-face follow-ups (n = 75) or to usual care over a 6-month period. * Intent-to-treat analyses revealed that patients in the intervention group showed significantly increased drug adherence rates, enhanced patient satisfaction and required fewer primary-care visits, compared with patients receiving usual care. Although the institutional cost of drug treatment was higher for intervention than usual care recipients, this difference was found to be minimal. No between-group differences were observed for clinical or functional outcomes. * The study was funded in part by an unrestricted educational grant from Pfizer Inc., US. Finley PR, et al. Impact of a collaborative care model on depression in a primary care setting: a randomized controlled trial. Pharmacotherapy 23: 1175-1185, No. 9, Sep 2003 800943426 1 PharmacoEconomics & Outcomes News 4 Oct 2003 No. 432 1173-5503/10/0432-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Pharmacist care improves outcomes in depression

Download PDF Report

Upload
buique
View
213
Download
0

Embed Size (px)

Citation preview

PharmacoEconomics & Outcomes News 432 - 4 Oct 2003

Pharmacist care improvesoutcomes in depression

A collaborative care intervention involving clinicalpharmacists can improve quality of care among primary-care patients with depression, and has a "favourableimpact on institutional resources", say US-basedresearchers.

They assessed outcomes among 125 members of ahealth maintenance organisation who startedantidepressant medication to treat depressivesymptoms; patients were randomised to an interventiongroup comprising pharmacist case management, patienteducation and frequent telephone and face-to-facefollow-ups (n = 75) or to usual care over a 6-monthperiod.* Intent-to-treat analyses revealed that patients inthe intervention group showed significantly increaseddrug adherence rates, enhanced patient satisfaction andrequired fewer primary-care visits, compared withpatients receiving usual care. Although the institutionalcost of drug treatment was higher for intervention thanusual care recipients, this difference was found to beminimal. No between-group differences were observedfor clinical or functional outcomes.* The study was funded in part by an unrestricted educational grantfrom Pfizer Inc., US.

Finley PR, et al. Impact of a collaborative care model on depression in a primarycare setting: a randomized controlled trial. Pharmacotherapy 23: 1175-1185, No. 9,Sep 2003 800943426